Top compounds associated with response to LRRC73


Feature Type Standardized
Nominal ANOVA
mRNA LY-2157299 CTRPv2 pan-cancer AAC -0.13 0.09
mRNA AZD0530 CCLE pan-cancer AAC 0.08 0.1
mRNA DBeQ CTRPv2 pan-cancer AAC 0.063 0.1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.053 0.1
mRNA AT-406 CTRPv2 pan-cancer AAC 0.079 0.1
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.061 0.1
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA Erlotinib CCLE pan-cancer AAC 0.075 0.1
Download CSV